SEC Form 4Coverage since May 22, 2026
$GYRE insider trading
Over the last 12 months, Gyre Therapeutics insiders reported no purchases and 5 sales totaling $455K across SEC Form 4 filings.
- Bought · 12m
- — 0 events
- Sold · 12m
- $455K 5 events
- Events · 12m
- 5 Form 4 filings, grouped
- Insiders · 12m
- 1 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $GYRE · 12Mvia TradingView
Top insiders · 12m
Ye WeiguoChief Operating Officer5× · $455K
All insider trades
5 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | Ye WeiguoChief Operating Officer · O | ▼ Sale | 11,000 | $6.25 | $69K | -1.5% | 3 tranches |
| Jun 11, 2026 | Ye WeiguoChief Operating Officer · O | ▼ Sale | 2,800 | $6.17 | $17K | -0.4% | — |
| Jun 10, 2026 | Ye WeiguoChief Operating Officer · O | ▼ Sale | 20,918 | $6.16 | $129K | -2.9% | 2 tranches |
| Jun 5, 2026 | Ye WeiguoChief Operating Officer · O | ▼ Sale | 34,976 | $6.25 | $219K | -4.8% | 2 tranches |
| May 22, 2026 | Ye WeiguoChief Operating Officer · O | ▼ Sale | 3,500 | $6.08 | $21K | -0.5% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $GYRE feed.